首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1917900

體外循環機市場－2026-2031年預測

Heart-Lung Machine Market - Forecast from 2026 to 2031

出版日期: 2026年01月08日 | 出版商:

Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計體外循環市場將以 6.64% 的複合年成長率成長，從 2025 年的 18.14 億美元成長到 2031 年的 26.69 億美元。

心肺體外迴圈（CPB）系統為核心的體外循環機市場是醫療設備業中至關重要且成熟的細分市場，在心臟直視手術和大型胸腔外科手術中提供必不可少的生命維持。這些複雜的系統能夠暫時取代心臟和肺的功能——為血液供氧、清除二氧化碳並維持體循環——使外科醫生能夠在靜止、無血的心臟上進行手術。作為心臟外科手術的基礎技術，該市場的發展受到全球心血管疾病負擔、灌注技術進步以及對不斷變化的醫療外科和經濟環境的策略調整的驅動。

市場需求的主要促進因素是全球心血管疾病（CVD）持續高發生率。冠狀動脈疾病、瓣膜疾病和先天性心臟疾病等疾病需要外科手術干預，例如冠狀動脈繞道手術手術（CABG）、瓣膜修復或置換術以及複雜先天性心臟疾病矯正手術。所有這些手術通常都需要使用體外循環機，因此心血管疾病的發生率與需要使用體外循環機的手術數量之間存在直接且持續的相關性。全球人口老化是許多心臟病的主要風險因素，進一步強化了這種潛在需求。

持續的技術創新是塑造競爭格局並推動現有系統更新換代的關鍵趨勢。創新主要集中在提高病人安全、改善生物相容性和最佳化手術流程等。關鍵研發領域包括：改進氧合器設計以改善氣體交換並減少預充量；開發具有整合資料管理功能的先進監測和安全系統；以及研發更俱生物相容性的迴路塗層以最大限度地減少體外循環相關的發炎反應和併發症風險。這些創新旨在減少術後併發症並改善患者預後。

一個顯著的市場趨勢是攜帶式或小型體外循環機的研發和廣泛應用。傳統的體外循環主機是體積龐大的固定資產。新一代移動系統具有更高的柔軟性，可用於混合手術室、院內急救轉運或空間受限的場所。雖然價格通常較高，但這些可攜式系統具有物流優勢，並符合手術環境多樣化的趨勢。這有望擴大各種臨床環境下獲得先進心臟支援的機會。

就應用而言，心臟外科手術仍然是體外循環（CPB）應用的主要領域。該設備在大多數心臟直視手術中發揮著不可替代的作用，也是設有心臟外科計畫的醫院的重要資本投資。隨著外科手術技術的拓展，納入了更多複雜和高風險的患者群體，例如老年患者和合併多種疾病的患者，對可靠且先進的體外循環技術的需求也進一步增強，以確保手術安全。

從地理上看，北美憑藉其先進的醫療基礎設施和龐大的心血管手術量，仍然是一個巨大的市場；而歐洲則是一個重要且穩定的市場，其特點是擁有完善的醫療保健體系、高標準的醫療服務以及對醫療技術的持續投入。歐洲市場受益於其對心血管健康的高度重視、完善的法規結構以及許多參與體外循環技術的主要醫療設備製造商的存在。

心臟外科醫療旅遊正成為一種新興趨勢，尤其是在亞洲。一些國家擁有先進的醫療基礎設施和尖端的外科手術技術，且費用低於西方國家，因此吸引了許多國際患者。這一趨勢也推動了主要醫院（作為醫療旅遊中心）對尖端手術設備的需求，包括最先進的心臟氧合器。這些醫院需要保持與世界一流技術的水平，才能保持競爭力。

競爭格局包括專注於體外循環技術的專業公司和產品組合涵蓋重症監護領域的綜合醫療設備製造商。競爭主要體現在技術領先性（例如，低預充量迴路、整合安全功能）、可靠性、易用性、為體外循環師提供的全面服務和培訓支援以及總體擁有成本 (TCO) 等方面。鑑於心肺體外迴圈(CPB) 的高風險性，在安全性和臨床支持方面擁有良好的過往記錄至關重要。

市場參與企業的策略活動專注於持續投資研發，以推出具有更高安全性和更友善使用者介面的新一代系統。各公司也與領先的心臟中心合作進行臨床研究，並根據實際手術和循環系統的回饋來改善產品設計。此外，他們致力於開發教育和培訓項目，以培養操作這項複雜技術所需的專業循環系統團隊。

總之，體外循環機市場對現代心臟外科手術至關重要，其需求受到全球心血管疾病負擔的強力支撐。儘管這項技術已日趨成熟，但它並非一成不變，而是不斷創新，透過提高生物相容性、安全性和操作柔軟性來改善患者預後。未來市場發展將受到系統小型化和行動化、人工智慧在即時監測和決策支援方面的應用，以及在以價值為導向的醫療保健環境中對具成本效益解決方案的需求等因素的影響。持續進行的心臟直視手術確保了心肺體外迴圈市場的長期存在，使其成為一項能夠挽救生命並提高患者生活品質的關鍵技術。

本報告的主要優勢：

深入分析：提供對主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
競爭格局：了解全球主要企業的策略舉措，並了解透過正確的策略進入市場的可能性。
市場促進因素和未來趨勢：探索市場促進因素和關鍵趨勢，並了解它們將如何影響未來的市場發展。
可操作的建議：利用這些見解，在動態環境中製定策略決策，發展新的業務流和收入來源。
受眾廣泛：適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業，且經濟實惠。

報告的主要用途

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

2021年至2025年的歷史數據和2026年至2031年的預測數據
成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
競爭定位、策略和市場佔有率分析
按業務板塊和地區（包括國家）分類的收入和預測評估
公司概況（策略、產品、財務資訊、關鍵發展等）

The heart-lung machine market, centered on cardiopulmonary bypass (CPB) systems, is a critical and mature segment within the medical device industry, providing essential life support during open-heart and major thoracic surgeries. These complex systems temporarily assume the functions of the heart and lungs-oxygenating blood, removing carbon dioxide, and maintaining systemic circulation-thereby allowing surgeons to operate on a still, bloodless heart. As a cornerstone technology enabling cardiac surgery, the market's evolution is driven by the global burden of cardiovascular disease, advancements in perfusion technology, and strategic adaptations to the changing surgical and economic landscape of healthcare.

The primary and most fundamental driver of market demand is the persistent and high global prevalence of cardiovascular diseases (CVDs). Conditions such as coronary artery disease, valvular heart disease, and congenital heart defects necessitate surgical interventions like coronary artery bypass grafting (CABG), valve repair or replacement, and complex congenital corrections. Each of these procedures typically requires cardiopulmonary bypass, creating a direct and sustained correlation between the incidence of CVDs and the procedural volume requiring heart-lung machines. The aging global population, a key risk factor for many cardiac conditions, further solidifies this underlying demand.

Continuous technological advancement is a key trend shaping the competitive landscape and driving the replacement cycle for existing systems. Innovation focuses on enhancing patient safety, improving biocompatibility, and optimizing surgical workflows. Key areas of development include the refinement of oxygenator designs for improved gas exchange and reduced priming volumes, advanced monitoring and safety systems with integrated data management, and the development of more biocompatible circuit coatings to minimize the inflammatory response and risk of complications associated with CPB. These innovations aim to reduce post-operative morbidity and support better patient outcomes.

A significant trend within the market is the development and increasing adoption of portable or compact heart-lung machines. Traditional CPB consoles are large, fixed pieces of capital equipment. Newer, more mobile systems offer greater flexibility, allowing for use in hybrid operating rooms, during emergency transport within a hospital, or in facilities with space constraints. While often representing a premium segment, these portable systems provide logistical advantages and support the trend toward more versatile surgical environments, potentially expanding access to advanced cardiac support in varied clinical settings.

From an application perspective, cardiac surgery remains the dominant and defining segment for heart-lung machine utilization. The device's role is irreplaceable in most open-heart procedures, making it a mandatory capital investment for hospitals with cardiac surgery programs. The expansion of surgical techniques to include more complex and high-risk patient populations, including older adults and those with multiple comorbidities, reinforces the need for reliable and advanced CPB technology to ensure procedural safety.

Geographically, while North America remains a large market due to its advanced healthcare infrastructure and high volume of cardiac procedures, Europe represents a significant and stable market characterized by well-established healthcare systems, high standards of care, and ongoing investment in medical technology. The European market benefits from a strong focus on cardiovascular health, supportive regulatory frameworks, and the presence of leading medical device manufacturers engaged in perfusion technology.

An emerging dynamic influencing certain regions, particularly in Asia, is the growth of medical tourism for cardiac surgery. Countries that have invested in high-quality healthcare infrastructure and offer advanced surgical capabilities at a lower cost than Western nations are attracting international patients. This trend drives demand for state-of-the-art surgical equipment, including modern heart-lung machines, in leading hospitals within these medical tourism hubs, as they must maintain technology parity with global standards to remain competitive.

The competitive environment includes specialized companies focused on perfusion technology and broader medical device corporations with critical care portfolios. Competition is based on technological leadership (e.g., low-priming volume circuits, integrated safety features), reliability, ease of use, comprehensive service and training support for perfusionists, and the total cost of ownership. Given the high-stakes nature of CPB, a proven track record of safety and clinical support is paramount.

Strategic activities by market participants emphasize sustained investment in research and development to introduce next-generation systems with enhanced safety profiles and user interfaces. Companies also engage in collaborations with leading cardiac centers to conduct clinical research and refine product design based on real-world surgical and perfusionist feedback. Furthermore, there is a focus on developing educational and training programs to support the specialized perfusionist workforce essential for operating this complex technology.

In conclusion, the heart-lung machine market is integral to the practice of modern cardiac surgery, with demand firmly anchored in the global burden of cardiovascular disease. While a mature technology, it is not static; innovation continues to focus on improving patient outcomes through enhanced biocompatibility, safety, and operational flexibility. Future market development will be influenced by the miniaturization and mobilization of systems, the integration of artificial intelligence for real-time monitoring and decision support, and the need for cost-effective solutions in value-based healthcare environments. The market's enduring role is assured by the continued necessity for open-heart surgery, ensuring that cardiopulmonary bypass remains a vital technology in saving and improving lives.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Heart-Lung Machine Market Segmentation

By Pump Type
Roller Pump
Centrifugal Pump
By Application
Heart Transplant
Lung Transplant
Heart Valve Surgery
Others
By End-User
Hospitals
Cardiac Centers
Others
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. HEART-LUNG MACHINE MARKET BY PUMP TYPE

5.1. Introduction
5.2. Roller Pump
5.3. Centrifugal Pump

6. HEART-LUNG MACHINE MARKET BY APPLICATION

6.1. Introduction
6.2. Heart Transplant
6.3. Lung Transplant
6.4. Heart Valve Surgery
6.5. Others

7. HEART-LUNG MACHINE MARKET BY END-USER

7.1. Introduction
7.2. Hospitals
7.3. Cardiac Centers
7.4. Others

8. HEART-LUNG MACHINE MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others